IPR2017-00807 - Argentum Pharmaceuticals LLC v. Cipla LtdReport Error
Details
PATENT NUMBER
APPL. NUMBER
10518016
STATUS
Settlement
FILING DATE
2017-02-02
INSTITUTION DATE
2017-08-21
TERMINATION DATE
2018-05-21
AUTHOR JUDGE
Timeline
Petition
Notice of Filing Date
Preliminary Response
Institution Decision
Request for Rehearing
Request for Rehearing
Rehearing Decision
Rehearing Decision
Motion to Terminate
Final Decision
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
Feb
Mar
Apr
May
Jun
Jul
Docket
1 | 2017-02-02 | Petitioner | Power of Attorney | Petitioner Power of Attorney |
2 | 2017-02-02 | Petitioner | Petition | Petition |
1001 | 2017-02-02 | Petitioner | U.S. Patent No. 8,168,620 | |
1002 | 2017-02-02 | Petitioner | Prosecution History of U.S. Patent No. 8,168,620 (Part 2 of 2) | |
1003 | 2017-02-02 | Petitioner | Declaration of Dr. Robert Schleimer | |
1004 | 2017-02-02 | Petitioner | Declaration of Dr. Maureen Donovan | |
1005 | 2017-02-02 | Petitioner | Meda Pharms. Inc. v. Apotex Inc. | |
1006 | 2017-02-02 | Petitioner | UK Patent Application GB 0213739.6 | |
1007 | 2017-02-02 | Petitioner | U.S. Patent No. 5,164,194 | |
1008 | 2017-02-02 | Petitioner | Astelin Label | |
1009 | 2017-02-02 | Petitioner | U.S. Patent No. 4,335,121 | |
1010 | 2017-02-02 | Petitioner | Flonase Label | |
1011 | 2017-02-02 | Petitioner | European Patent Application No. 0780127 | |
1012 | 2017-02-02 | Petitioner | PCT Publication No. WO 98/48839 | |
1013 | 2017-02-02 | Petitioner | British Pharmaceutical Codex | |
1014 | 2017-02-02 | Petitioner | U.S. Patent Publication No. 20040136918 | |
1015 | 2017-02-02 | Petitioner | Falser, N., et al. | |
1016 | 2017-02-02 | Petitioner | Kusters, S., et al. | |
1017 | 2017-02-02 | Petitioner | Stellato, C., et al. | |
1018 | 2017-02-02 | Petitioner | Johnson, M. | |
1019 | 2017-02-02 | Petitioner | Dykewicz, Mark S., et al. | |
1020 | 2017-02-02 | Petitioner | Stoloff, R., et al. | |
1021 | 2017-02-02 | Petitioner | Berger, W. E. et al. | |
1022 | 2017-02-02 | Petitioner | Cauwenberge, P. et al. | |
1023 | 2017-02-02 | Petitioner | Spector, S. | |
1024 | 2017-02-02 | Petitioner | Bousquet et al. | |
1025 | 2017-02-02 | Petitioner | Markham, A., et al. | |
1027 | 2017-02-02 | Petitioner | Ansel, et al. | |
1030 | 2017-02-02 | Petitioner | Advair Diskus Prescribing Information | |
1031 | 2017-02-02 | Petitioner | Juniper, E | |
1033 | 2017-02-02 | Petitioner | Wade & Weller | |
1034 | 2017-02-02 | Petitioner | Ratner, P., et al. (1998) | |
1035 | 2017-02-02 | Petitioner | Drouin, M., et al. | |
1036 | 2017-02-02 | Petitioner | Simpson, R. | |
1038 | 2017-02-02 | Petitioner | Brooks, C. et al. | |
1039 | 2017-02-02 | Petitioner | Juniper, E F | |
1040 | 2017-02-02 | Petitioner | Benincasa, C. & Lloyd, R.S. | |
1041 | 2017-02-02 | Petitioner | Galant, S. and Wilkinson, R. | |
1042 | 2017-02-02 | Petitioner | Schleimer, R. | |
1045 | 2017-02-02 | Petitioner | Ratner, Paul H., et al. (2008) | |
1046 | 2017-02-02 | Petitioner | IMITREX Prescribing Information | |
1047 | 2017-02-02 | Petitioner | NASACORT AQ Prescribing Information | |
1048 | 2017-02-02 | Petitioner | Rabago, David, et al. | |
1049 | 2017-02-02 | Petitioner | Budavari, S., et al. | |
1050 | 2017-02-02 | Petitioner | Ratner (1994) | |
1051 | 2017-02-02 | Petitioner | Curriculum Vitae of Dr. Robert Schleimer | |
1052 | 2017-02-02 | Petitioner | Curriculum Vitae of Dr. Maureen Donovan | |
1053 | 2017-02-02 | Petitioner | Patent Certification for U.S. Patent No. 5,164,194 - Astelin Nasal Spray (2000) | |
1054 | 2017-02-02 | Petitioner | Avicel RC-591 | |
3 | 2017-02-23 | Potential Patent Owner | Power of Attorney | Cipla Limited's Power of Attorney |
4 | 2017-02-23 | Potential Patent Owner | Mandatory Notice | Cipla Limited's Mandatory Notices |
5 | 2017-02-28 | Board | Notice of Filing Date | Notice of Accord Filing Date |
6 | 2017-05-30 | Potential Patent Owner | Cipla Ltd.'s Exhibit List | |
7 | 2017-05-30 | Potential Patent Owner | Preliminary Response | Cipla Ltd.'s Patent Owner Preliminary Response |
8 | 2017-05-30 | Potential Patent Owner | Other | Patent Owner Cipla Limited's Motion for Pro Hac Vice Admission of Uma N. Everett Under 37 CFR ¿¿ 42.10(c) |
2001 | 2017-05-30 | Potential Patent Owner | Warner Carr, M.D. Declaration | |
2002 | 2017-05-30 | Potential Patent Owner | Warner Carr, M.D. Curriculum Vitae | |
2003 | 2017-05-30 | Potential Patent Owner | Alexander Dominic D'Addio, Ph.D. Declaration | |
2004 | 2017-05-30 | Potential Patent Owner | Alexander Dominic D'Addio, Ph.D. Curriculum Vitae | |
2005 | 2017-05-30 | Potential Patent Owner | John C. Jarosz Declaration | |
2006 | 2017-05-30 | Potential Patent Owner | John C. Jarosz Curriculum Vitae | |
2007 | 2017-05-30 | Potential Patent Owner | Hugh David Charles Smyth, Ph.D. Declaration | |
2008 | 2017-05-30 | Potential Patent Owner | Hugh David Charles Smyth, Ph.D. Curriculum Vitae | |
2009 | 2017-05-30 | Potential Patent Owner | Complaint for Patent Infringement, December 2, 2014, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-UNA (D. Del.) | |
2010 | 2017-05-30 | Potential Patent Owner | Complaint for Patent Infringement, September 9, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Perrigo UK Finko Limited Partnership, Perrigo Company and Perrigo Pharmaceuticals Co., Case No. 1:16-cv-00794-LPS (D. Del.) | |
2011 | 2017-05-30 | Potential Patent Owner | Expert Report of Robert P. Schleimer, Ph.D., August 19, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2012 | 2017-05-30 | Potential Patent Owner | Expert Rebuttal Report of Robert P. Schleimer, Ph.D., July 29, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2013 | 2017-05-30 | Potential Patent Owner | Expert Reply Report of Robert P. Schleimer, Ph.D., August 19, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2014 | 2017-05-30 | Potential Patent Owner | Dr. Maureen Donovan Deposition transcript, October 7, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2015 | 2017-05-30 | Potential Patent Owner | Expert Report of Maureen D. Donovan, Ph.D., June 30, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2016 | 2017-05-30 | Potential Patent Owner | Expert Reply Report of Maureen D. Donovan, Ph.D., August 19, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2017 | 2017-05-30 | Potential Patent Owner | Publicly Filed Proposed Joint Pretrial Order, November 10, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D.I.137) (Redactions in Original) | |
2018 | 2017-05-30 | Potential Patent Owner | Bench Trial Transcript, Volume A, December 13, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2019 | 2017-05-30 | Potential Patent Owner | Bench Trial Transcript, Volume B, December 14, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2020 | 2017-05-30 | Potential Patent Owner | Bench Trial Transcript, Volume C, December 15, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2021 | 2017-05-30 | Potential Patent Owner | Bench Trial Transcript, Volume D, December 16, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2022 | 2017-05-30 | Potential Patent Owner | Plaintiffs' Proposed Findings of Fact, January 10, 2017, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 155) | |
2023 | 2017-05-30 | Potential Patent Owner | Defendants' Proposed Finding of Facts, January 10, 2017, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 156) | |
2024 | 2017-05-30 | Potential Patent Owner | Defendants' Opening Post-Trial Brief, January 24, 2017, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 158) | |
2025 | 2017-05-30 | Potential Patent Owner | Dr. Robert Schleimer Deposition transcript, September 29, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) | |
2026 | 2017-05-30 | Potential Patent Owner | Gennaro, A. R. Remington's Pharmaceutical Sciences (17th ed., 1985), Ch. 80: 1455-1477; Ch. 82: 1478-1491; Ch. 84:1492-1517 | |
2027 | 2017-05-30 | Potential Patent Owner | Accolate Approval Letter and Label, Application Number 20-547/S011, Zeneca Pharmaceuticals | |
2028 | 2017-05-30 | Potential Patent Owner | Avomeen Analytical Services Report, June 30, 2016 (PTX0129) | |
2029 | 2017-05-30 | Potential Patent Owner | Expert Report of Dr. Matthew J. Herpin and Corresponding Documents (PTX1663) | |
2030 | 2017-05-30 | Potential Patent Owner | Expert Report of Dr. Govindarajan and Corresponding Documents (PTX1664) | |
2031 | 2017-05-30 | Potential Patent Owner | Duonase Imitator Product Labels (PTX0026) | |
2032 | 2017-05-30 | Potential Patent Owner | Allegra-D Approval Letter, Application Number 20786, Approved December 24, 1997, (PTX0126) | |
2034 | 2017-05-30 | Potential Patent Owner | Physicians' Desk Reference, 54th ed., pp. 1343-1344, 2404-2406, 2781-2783 (2000) | |
2035 | 2017-05-30 | Potential Patent Owner | Riordan, John. An Introduction to Combinatorial Analysis (1958), Ch. 1: 1-18 | |
2036 | 2017-05-30 | Potential Patent Owner | Zyrtec-D FDA Label, Approved August 10, 2001 | |
2037 | 2017-05-30 | Potential Patent Owner | Argentum Pharmaceuticals Website, accessed May 17, 2017 | |
2038 | 2017-05-30 | Potential Patent Owner | Khan 2000 (PTX0194) | |
2039 | 2017-05-30 | Potential Patent Owner | Flonase¿¿ Label 1998 (PTX0059) | |
2040 | 2017-05-30 | Potential Patent Owner | British Pharmaceutical Codex 1973 (PTX0193) | |
2041 | 2017-05-30 | Potential Patent Owner | Howarth 2000 (PTX0337) | |
2042 | 2017-05-30 | Potential Patent Owner | Nielsen 2001 (PTX0338) | |
2043 | 2017-05-30 | Potential Patent Owner | Shenfield 1986 (DTX-048) | |
2044 | 2017-05-30 | Potential Patent Owner | Michael 2001 (PTX0179) | |
2045 | 2017-05-30 | Potential Patent Owner | Hampel 2010 (PTX0230) | |
2046 | 2017-05-30 | Potential Patent Owner | Weiler 1997 (PTX0329) | |
2047 | 2017-05-30 | Potential Patent Owner | Blaiss 2001 (PTX0058) | |
2048 | 2017-05-30 | Potential Patent Owner | DataMonitor, July 2010 (PTX0396) | |
2049 | 2017-05-30 | Potential Patent Owner | 2006 Cipla-Meda License Agreement with Quality Agreement (PTX1016) | |
2050 | 2017-05-30 | Potential Patent Owner | 2011 First Amendment to Cipla-Meda Agreement (PTX0282) | |
2051 | 2017-05-30 | Potential Patent Owner | Physicians' Desk Reference, 54th ed., pp. 2783- 2786 (2000) | |
2052 | 2017-05-30 | Potential Patent Owner | Leung 2012 (PTX0029) | |
2053 | 2017-05-30 | Potential Patent Owner | Global Data September 2015 (PTX0397) | |
2054 | 2017-05-30 | Potential Patent Owner | Astelin¿¿ Day Life CyclePlan November 2002 (PTX1005) | |
2055 | 2017-05-30 | Potential Patent Owner | MedPointe Product & Process Development Program Priorities and Issues September 2002 (PTX0143) | |
2056 | 2017-05-30 | Potential Patent Owner | Astelin¿¿ Nasal Spray Life Cycle Management Projects (Preliminary Plan) (PTX1006) | |
2057 | 2017-05-30 | Potential Patent Owner | 2006.02.06 Email from Paul Edick to Dennis Fuge re: Pfeiffer Bi Dose Nasal Spray System (PTX0149) | |
2058 | 2017-05-30 | Potential Patent Owner | 2006.03.21 Email and attachment from Kalidas Kale to Alex D'Addio re: Astelin ¿¿¿ Flonase Combination Product Feasibility Assessment Plan (PTX0151) | |
2059 | 2017-05-30 | Potential Patent Owner | U.S. Patent No. 8,071,073 | |
2060 | 2017-05-30 | Potential Patent Owner | U.S. Patent No. 8,518,919 | |
2061 | 2017-05-30 | Potential Patent Owner | MedPointe Laboratory Notebook No. 1044 - Excerpts (PTX0142) | |
2062 | 2017-05-30 | Potential Patent Owner | IMS data for U.S. allergic rhinitis products, 01.2012-04.2016 (PTX0929) | |
2064 | 2017-05-30 | Potential Patent Owner | 2011.11.02 Email and attachment from Ashwini Dumaswala to Bryan Roecklein re: 2012 Dymista¿¿ Strategic Plan (PTX1118) | |
2065 | 2017-05-30 | Potential Patent Owner | All Products - Apotex Products: United States, accessed June 22, 2016 | |
2066 | 2017-05-30 | Potential Patent Owner | Dymista¿¿ Prescribing Information 2015 (PTX0024) | |
2067 | 2017-05-30 | Potential Patent Owner | Drug Approval Package: Dymista¿¿, Approved May 1, 2012 (PTX0392) | |
2068 | 2017-05-30 | Potential Patent Owner | Meda AB Interim Report Jan.-Sept. 2012 (PTX0393) | |
2069 | 2017-05-30 | Potential Patent Owner | Cipla Website, accessed June 28, 2016 (PTX0379) | |
2070 | 2017-05-30 | Potential Patent Owner | Duonase Nasal Spray ¿¿¿ Prescribing Information (PTX0134) | |
2071 | 2017-05-30 | Potential Patent Owner | Cipla Website,accessed June 28, 2016 (PTX0380) | |
2072 | 2017-05-30 | Potential Patent Owner | IMS data for Duonase competitor products, 2005-2016 (PTX0816) | |
2073 | 2017-05-30 | Potential Patent Owner | Dymista¿¿ briefing document (PTX1654) | |
2074 | 2017-05-30 | Potential Patent Owner | 2014.11.14 Email and attachment from Stuart Loeschto Betsy Orrison re: Dymista¿¿ US Marketing Plan 2015 (PTX0271) | |
2075 | 2017-05-30 | Potential Patent Owner | Dymista¿¿ Competitor Benchmarking Presentation 2012 (PTX0926) | |
2076 | 2017-05-30 | Potential Patent Owner | Meda ¿¿¿ 2016 Dymista¿¿ Brand Plan (PTX0406) | |
2077 | 2017-05-30 | Potential Patent Owner | fda.gov,"Prescription to Over-the-Counter (OTC) Switch List," accessed June 28, 2016 (PTX0407) | |
2078 | 2017-05-30 | Potential Patent Owner | Johnson & Johnson Press Release,"RHINOCORT¿¿ Allergy Spray Now Available Over The Counter Nationally," dated February 8, 2016 | |
2079 | 2017-05-30 | Potential Patent Owner | 2011.11.02 Email and attachment from Ashwini Dumaswala to Bryan Roecklein re: 2012 Dymista¿¿ Strategy Plan (PTX0267) | |
2080 | 2017-05-30 | Potential Patent Owner | MEDA Presentation (2001) (PTX0871) | |
2081 | 2017-05-30 | Potential Patent Owner | FDA.gov, "First-Time Generic Drug Approvals - March 2016," (accessed June 28, 2016) (PTX0424) | |
2082 | 2017-05-30 | Potential Patent Owner | Renavatio Presentation & Meda Presentation (PTX0426) | |
2083 | 2017-05-30 | Potential Patent Owner | Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, June 17, 2015 (PTX0914) | |
2084 | 2017-05-30 | Potential Patent Owner | Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, June 16, 2015 (PTX0916) | |
2085 | 2017-05-30 | Potential Patent Owner | Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, November 26, 2012 (PTX0917) | |
2086 | 2017-05-30 | Potential Patent Owner | Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, June 29, 2015 (PTX0915) | |
2087 | 2017-05-30 | Potential Patent Owner | Cipla Duonase Marketing Presentation (PTX0315) | |
2088 | 2017-05-30 | Potential Patent Owner | Meda/Cipla Powerpoint ¿¿¿ Complete Picture (PTX0412) | |
2089 | 2017-05-30 | Potential Patent Owner | healthcare.utah, "The Difference Between AR and Sinusitis," accessed June 28, 2016 (PTX0429) | |
2090 | 2017-05-30 | Potential Patent Owner | Family Allergy & Asthma Care of Montana Website, accessed June 28, 2016 (PTX0430) | |
2091 | 2017-05-30 | Potential Patent Owner | Bousquet "Allergic Rhinitis," accessed June 28, 2016 (PTX0431) | |
2092 | 2017-05-30 | Potential Patent Owner | Samuelson and Nordhaus 2010 (PTX0415) | |
2093 | 2017-05-30 | Potential Patent Owner | Dymista¿¿ Marketing Plan 2016 (PTX0438) | |
2094 | 2017-05-30 | Potential Patent Owner | Dymista¿¿ Formulary Coverage Powerpoint 2014 (PTX0892) | |
2095 | 2017-05-30 | Potential Patent Owner | Meda Memorandum re: CVS Caremark Formulary Decisions 2015 (PTX0447) | |
2096 | 2017-05-30 | Potential Patent Owner | Bagwell 2007 (PTX0432) | |
2097 | 2017-05-30 | Potential Patent Owner | Ching 2010 (PTX0433) | |
2098 | 2017-05-30 | Potential Patent Owner | Berndt 2001 (PTX0434) | |
2099 | 2017-05-30 | Potential Patent Owner | Bloomberg Website, accessed May 19, 2017 | |
2100 | 2017-05-30 | Potential Patent Owner | Newsroom Website accessed May 19, 2017 | |
2101 | 2017-05-30 | Potential Patent Owner | Apotex Press Release "Apotex Launches First Generic Version of Merck's Nasonex¿¿," dated March 24, 2016 | |
2103 | 2017-05-30 | Potential Patent Owner | The United States Pharmacopeia 1999 (PTX0188) | |
2104 | 2017-05-30 | Potential Patent Owner | Lieberman 1996 (PTX0177) | |
2105 | 2017-05-30 | Potential Patent Owner | Shin Etsu Pharmacoat USP Hypromellose Brochure (2005) (PTX0186) | |
2107 | 2017-05-30 | Potential Patent Owner | Gennaro 2000 (PTX0184) | |
2110 | 2017-05-30 | Potential Patent Owner | Kibbe 2000 (PTX0198) | |
2111 | 2017-05-30 | Potential Patent Owner | Michael 2000 (PTX0180) | |
2112 | 2017-05-30 | Potential Patent Owner | Allen 1998 (PTX0167) | |
2113 | 2017-05-30 | Potential Patent Owner | Lieberman 1996 (PTX0192) | |
2114 | 2017-05-30 | Potential Patent Owner | Meda Highlights of Prescribing Information 2015 (PTX0154) | |
2120 | 2017-05-30 | Potential Patent Owner | MedPointe Product & Process Development, Program Priorities and Issues - November 18, 2002, "Commercial Product Technical Support" (PTX0144) | |
2121 | 2017-05-30 | Potential Patent Owner | 2006.02.06 Email from Richard Spivey to Alex D'Addio re: Pfeiffer Bi Dose Nasal Spray System (PTX0150) | |
2122 | 2017-05-30 | Potential Patent Owner | 2003.11.11 Email and attachment from Mary Lehr to Gul Balwani (PTX0255) | |
2123 | 2017-05-30 | Potential Patent Owner | IMS data for Indian allergic rhinitis nasal spray products, December 2010-December 2014 (PTX0823) | |
2124 | 2017-05-30 | Potential Patent Owner | IMS data for Indian allergic rhinitis nasal sprays products, March 2013 ¿¿¿ March 2017 | |
2126 | 2017-05-30 | Potential Patent Owner | IMS data for Duonase competitor products, 2005-2017 | |
2127 | 2017-05-30 | Potential Patent Owner | 2017.03.21 Email from Mike Houston to Adam LaRock re IPR2017-00807 | |
2129 | 2017-05-30 | Potential Patent Owner | Center for Drug Evaluation and Research 2000 (PTX0025) | |
2130 | 2017-05-30 | Potential Patent Owner | webmd.com, "FDA Oks Generic Version of Flonase," accessed May 26, 2017 | |
2131 | 2017-05-30 | Potential Patent Owner | "What is a Tiered Formulary and What Does it Mean for Me?," accessed May 26, 2017 | |
2132 | 2017-05-30 | Potential Patent Owner | IMS data for U.S. allergic rhinitis products, May 2011 - April 2017 | |
2133 | 2017-05-30 | Potential Patent Owner | Bousquet 2001 (PTX0326) | |
2134 | 2017-05-30 | Potential Patent Owner | Memorandum Opinion, May 12, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 114) | |
2135 | 2017-05-30 | Potential Patent Owner | Wade and Weller 1994 | |
2136 | 2017-05-30 | Potential Patent Owner | Talbot 1997 | |
2138 | 2017-05-30 | Potential Patent Owner | DataMonitor ¿¿¿ "Commercial and Stakeholder Perspectives: Allergic Rhinitis," September 2004 (PTX0098) | |
2139 | 2017-05-30 | Potential Patent Owner | Affidavit in Support of Motion for Pro Hac Vice Admission of Uma N. Everett | |
2140 | 2017-05-30 | Potential Patent Owner | Declaration of Adam C. LaRock | |
9 | 2017-06-02 | Potential Patent Owner | Other | Patent Owner's Updated Mandatory Notices |
10 | 2017-06-08 | Board | Other | Order Granting Patent Owner Motion for Pro Hac Vice Admission of Uma N. Everett |
11 | 2017-08-21 | Board | Institution Decision | Trial Instituted Document |
12 | 2017-08-21 | Board | Other | Scheduling Order |
13 | 2017-09-05 | Petitioner | Request for Rehearing | Petitioner's Request for Rehearing |
14 | 2017-09-05 | Potential Patent Owner | Other | Cipla Limited's Objections to Evidence |
15 | 2017-09-05 | Potential Patent Owner | Request for Rehearing | Cipla Limited's Request for Rehearing |
16 | 2017-09-05 | Petitioner | Other | Petitioner's Objections to Evidence |
17 | 2017-10-05 | Potential Patent Owner | Other | Notice of Deposition of Robert P. Schleimer, Ph.D. |
18 | 2017-10-05 | Potential Patent Owner | Other | Notice of Deposition of Maureen D. Donovan, Ph.D. |
19 | 2017-10-30 | Board | Rehearing Decision | Denying Petitioners Request for Rehearing 37 C.F.R. sec 42.71(d) |
20 | 2017-10-31 | Board | Rehearing Decision | Decision - Denying Patent Owner's Request for Rehearing |
21 | 2017-11-20 | Potential Patent Owner | Response | Patent Owner Response |
22 | 2017-11-20 | Potential Patent Owner | Exhibit List | |
23 | 2017-11-20 | Potential Patent Owner | Other | Motion to Seal |
2145 | 2017-11-20 | Potential Patent Owner | USPN 6,599,914 | |
2146 | 2017-11-20 | Potential Patent Owner | US Utility 09_841,506 | |
2147 | 2017-11-20 | Potential Patent Owner | Second Carr Declaration | |
2148 | 2017-11-20 | Potential Patent Owner | Second D'Addio Declaration | |
2149 | 2017-11-20 | Potential Patent Owner | Second Jarosz Declaration | |
2156 | 2017-11-20 | Potential Patent Owner | Handbook of Pharmaceutical Excipients 2000 | |
2157 | 2017-11-20 | Potential Patent Owner | Hayashi 1999 | |
2158 | 2017-11-20 | Potential Patent Owner | Schleimer Deposition Transcript | |
2159 | 2017-11-20 | Potential Patent Owner | Donovan Deposition Transcript | |
2160 | 2017-11-20 | Potential Patent Owner | Amended Default Protective Order | |
2161 | 2017-11-20 | Potential Patent Owner | Barnes 2001 | |
2162 | 2017-11-20 | Potential Patent Owner | Andy 2002 | |
2163 | 2017-11-20 | Potential Patent Owner | MMIT Dymista Formulary Information | |
2164 | 2017-11-20 | Potential Patent Owner | Sept. 7, 2007 FDA Letter | |
2165 | 2017-11-20 | Potential Patent Owner | May 19. 2008 FDA Letter | |
2167 | 2017-11-20 | Potential Patent Owner | Sherman 1951 | |
2168 | 2017-11-20 | Potential Patent Owner | Updated Jarosz CV | |
2169 | 2017-11-20 | Potential Patent Owner | Clarinex Label - 2001 | |
2170 | 2017-11-20 | Potential Patent Owner | Storms 1997 | |
2171 | 2017-11-20 | Potential Patent Owner | Cipla Duonase Manufacturing Guide - PUBLIC | |
2172 | 2017-11-20 | Potential Patent Owner | Cipla Duonase Manufacturing Guide - PUBLIC | |
2173 | 2017-11-20 | Potential Patent Owner | Dymista Investigation Report | |
2174 | 2017-11-20 | Potential Patent Owner | Dymista NDA Excerpt - PUBLIC | |
2175 | 2017-11-20 | Potential Patent Owner | Cipla Duonase Stability Testing Form - PUBLIC | |
2176 | 2017-11-20 | Potential Patent Owner | Second Smyth Declaration - PUBLIC | |
24 | 2018-01-29 | Petitioner | Other | Notice of Deposition - Smyth |
25 | 2018-01-29 | Petitioner | Other | Petitioner's Updated Mandatory Notice |
26 | 2018-02-02 | Petitioner | Other | Stipulation Concerning Schedule |
27 | 2018-02-05 | Petitioner | Other | Notice of Deposition - Carr |
28 | 2018-02-14 | Petitioner | Other | Notice of Deposition - D'Addio |
29 | 2018-03-06 | Petitioner | Other | Petitioner's Motion to Seal |
30 | 2018-03-06 | Petitioner | Reply | PETITIONER REPLY TO PATENT OWNER RESPONSE |
31 | 2018-03-06 | Petitioner | Petitioner's Exhibit List of March 6, 2018 | |
1055 | 2018-03-06 | Petitioner | Dr. Accetta Patient Record (1998) | |
1056 | 2018-03-06 | Petitioner | US 6,417,206 | |
1057 | 2018-03-06 | Petitioner | Business Wire | |
1058 | 2018-03-06 | Petitioner | Center for Drug Evaluation and Research | |
1059 | 2018-03-06 | Petitioner | GlaxoSmithKline | |
1060 | 2018-03-06 | Petitioner | Meda AB | |
1061 | 2018-03-06 | Petitioner | Generic Astelin | |
1062 | 2018-03-06 | Petitioner | Cetirizine & Levocetirizine | |
1063 | 2018-03-06 | Petitioner | Fexofenadine | |
1064 | 2018-03-06 | Petitioner | Loratadine & Desloratadine | |
1065 | 2018-03-06 | Petitioner | Durie | |
1066 | 2018-03-06 | Petitioner | Meda, "Annual Report 2015." | |
1067 | 2018-03-06 | Petitioner | Meda, "Annual Report 2014." | |
1068 | 2018-03-06 | Petitioner | Meda, "Annual Report 2013." | |
1069 | 2018-03-06 | Petitioner | Prescription Drug Pricing in the Private Sector | |
1070 | 2018-03-06 | Petitioner | Beclomethasone | |
1071 | 2018-03-06 | Petitioner | Sur | |
1072 | 2018-03-06 | Petitioner | Brozek | |
1073 | 2018-03-06 | Petitioner | 2010 Top 200 Branded Drugs by Retail Dollars | |
1074 | 2018-03-06 | Petitioner | Top 200 Brand-Name Drugs by Retail Dollars in 2005 | |
1075 | 2018-03-06 | Petitioner | Grabowski | |
1076 | 2018-03-06 | Petitioner | Meda, "Annual Report 2012." | |
1077 | 2018-03-06 | Petitioner | DiMasi | |
1078 | 2018-03-06 | Petitioner | Summary Application Review: Application Number 22-203 | |
1079 | 2018-03-06 | Petitioner | Meda, "Annual Report 2009." | |
1080 | 2018-03-06 | Petitioner | 2010 top 200 Generic Drugs by Total Prescriptions | |
1081 | 2018-03-06 | Petitioner | Voet | |
1082 | 2018-03-06 | Petitioner | Shadowen | |
1083 | 2018-03-06 | Petitioner | Dymista NDA Approval | |
1084 | 2018-03-06 | Petitioner | Carrier | |
1085 | 2018-03-06 | Petitioner | Herper | |
1086 | 2018-03-06 | Petitioner | Prescription Drug Pricing in the Private Sector | |
1087 | 2018-03-06 | Petitioner | Scherer | |
1088 | 2018-03-06 | Petitioner | How Increased Competition from Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry | |
1089 | 2018-03-06 | Petitioner | Danzon | |
1090 | 2018-03-06 | Petitioner | Concepts in Managed Care Pharmacy | |
1091 | 2018-03-06 | Petitioner | Danzon - Health Insurance | |
1092 | 2018-03-06 | Petitioner | ABA Section of Antitrust Law | |
1093 | 2018-03-06 | Petitioner | Promotional Spending for Prescription Drugs | |
1094 | 2018-03-06 | Petitioner | Scherer | |
1095 | 2018-03-06 | Petitioner | Lu | |
1096 | 2018-03-06 | Petitioner | Yi | |
1097 | 2018-03-06 | Petitioner | Patwardhan | |
1098 | 2018-03-06 | Petitioner | Fugh-Berman | |
1099 | 2018-03-06 | Petitioner | Elliott | |
1100 | 2018-03-06 | Petitioner | Allan | |
1101 | 2018-03-06 | Petitioner | Shrank | |
1102 | 2018-03-06 | Petitioner | Shelley | |
1103 | 2018-03-06 | Petitioner | Apotex Corp. | |
1104 | 2018-03-06 | Petitioner | Perrigo | |
1105 | 2018-03-06 | Petitioner | DocGuide.com | |
1106 | 2018-03-06 | Petitioner | Apotex Launches First Generic Version of Merck's Nasonex | |
1107 | 2018-03-06 | Petitioner | Vaidyanathan | |
1108 | 2018-03-06 | Petitioner | Flunisolide | |
1109 | 2018-03-06 | Petitioner | Claritin-D Drug Approval | |
1110 | 2018-03-06 | Petitioner | Nasalide Drug Approval | |
1111 | 2018-03-06 | Petitioner | Traimcinolone | |
1112 | 2018-03-06 | Petitioner | NDC Director - Ticanase | |
1113 | 2018-03-06 | Petitioner | Fluticasone Propionate | |
1114 | 2018-03-06 | Petitioner | Olopatadine | |
1115 | 2018-03-06 | Petitioner | Budesonide | |
1116 | 2018-03-06 | Petitioner | Mometasone | |
1117 | 2018-03-06 | Petitioner | Mahr | |
1118 | 2018-03-06 | Petitioner | Parliament of India Report | |
1119 | 2018-03-06 | Petitioner | Kataria | |
1120 | 2018-03-06 | Petitioner | Bhargava | |
1121 | 2018-03-06 | Petitioner | Pfizer India | |
1122 | 2018-03-06 | Petitioner | 2010 Top 200 Branded Drugs by Total Prescriptions | |
1123 | 2018-03-06 | Petitioner | Beconase AQ | |
1124 | 2018-03-06 | Petitioner | McDuff | |
1125 | 2018-03-06 | Petitioner | Tidwell | |
1126 | 2018-03-06 | Petitioner | Ayalew | |
1127 | 2018-03-06 | Petitioner | Weigmann | |
1128 | 2018-03-06 | Petitioner | Gottlieb | |
1129 | 2018-03-06 | Petitioner | Morton | |
1130 | 2018-03-06 | Petitioner | Authorized Generic Drugs: Short-Term Effects and Long-Term Impact | |
1131 | 2018-03-06 | Petitioner | Apotex - Pharmacy Times | |
1132 | 2018-03-06 | Petitioner | Canadian Generic Drug Sector Study | |
1133 | 2018-03-06 | Petitioner | Morton | |
1134 | 2018-03-06 | Petitioner | Bhadoria | |
1135 | 2018-03-06 | Petitioner | India Pharma Inc. | |
1136 | 2018-03-06 | Petitioner | Salunke | |
1137 | 2018-03-06 | Petitioner | Gilbert | |
1138 | 2018-03-06 | Petitioner | Lanjouw | |
1139 | 2018-03-06 | Petitioner | Curriculum Vitae of John C. Staines, Jr. | |
1140 | 2018-03-06 | Petitioner | Declaration of John C. Staines, Jr. | |
1141 | 2018-03-06 | Petitioner | Deposition Transcript of Dr. Alexander Dominic D¿¿¿Addio | |
1142 | 2018-03-06 | Petitioner | Deposition Transcript of Dr. Warner W. Carr | |
1143 | 2018-03-06 | Petitioner | Deposition Transcript of Dr. Hugh David Charles Smyth | |
1144 | 2018-03-06 | Petitioner | Second Declaration of Dr. Robert Schleimer | |
1146 | 2018-03-06 | Petitioner | Dell and Colliopoulos | |
1147 | 2018-03-06 | Petitioner | GREIFF | |
1148 | 2018-03-06 | Petitioner | Han | |
1149 | 2018-03-06 | Petitioner | Nairn | |
1150 | 2018-03-06 | Petitioner | Rhinolast Nasal Spray | |
1151 | 2018-03-06 | Petitioner | Schmidt | |
1152 | 2018-03-06 | Petitioner | U.S. Patent No. 3,636,200 | |
1153 | 2018-03-06 | Petitioner | U.S. Patent No. 5,196,436 | |
1154 | 2018-03-06 | Petitioner | U.S. Patent No. 5,658,919 | |
1155 | 2018-03-06 | Petitioner | U.S. Patent No. 6,565,832 | |
1156 | 2018-03-06 | Petitioner | PCT Publication No. WO01/28563 | |
1157 | 2018-03-06 | Petitioner | Patent Assignment | |
1158 | 2018-03-06 | Petitioner | E-mail: February 20, 2018 to March 5, 2018 | |
1159 | 2018-03-06 | Petitioner | Berger | |
1160 | 2018-03-06 | Petitioner | Corren | |
1161 | 2018-03-06 | Petitioner | LaForce | |
1162 | 2018-03-06 | Petitioner | Berger | |
1163 | 2018-03-06 | Petitioner | Updated Curriculum Vitae of Dr. Robert Schleimer | |
1164 | 2018-03-06 | Petitioner | McNeely | |
1165 | 2018-03-06 | Petitioner | Second Declaration of Dr. Maureen Donovan (redacted version) | |
1166 | 2018-03-06 | Petitioner | U.S. Patent No. 8,933,060 | |
1167 | 2018-03-06 | Petitioner | U.S. Patent No. 8,304,405 | |
1168 | 2018-03-06 | Petitioner | Kublik | |
32 | 2018-03-13 | Potential Patent Owner | Other | Patent Owner's Objections to Evidence As Of March 13, 2018 |
33 | 2018-03-20 | Potential Patent Owner | Other | 2nd Donovan Deposition Notice |
34 | 2018-03-20 | Potential Patent Owner | Other | 2nd Schleimer Deposition Notice |
35 | 2018-03-29 | Potential Patent Owner | Other | Staines Deposition Notice |
36 | 2018-04-02 | Potential Patent Owner | Other | Stipulation Concerning Schedule |
37 | 2018-04-09 | Potential Patent Owner | Other | Request for Oral Argument |
38 | 2018-04-09 | Potential Patent Owner | Other | Cipla Ltd.'s Corrected Request for Oral Argument |
39 | 2018-04-09 | Petitioner | Other | Request for Oral Argument |
40 | 2018-04-10 | Board | Other | ORDER Oral Hearing 37 C.F.R. 42.70 |
41 | 2018-04-10 | Petitioner | Other | Petitioner's Motion to Exclude Evidence |
42 | 2018-04-10 | Petitioner | Other | Petitioner's Exhibit List of April 10, 2018 |
43 | 2018-04-10 | Potential Patent Owner | Other | Motion to Exclude |
44 | 2018-04-10 | Potential Patent Owner | Other | Motion for Observations on Cross Exam |
45 | 2018-04-10 | Potential Patent Owner | Updated Exhibit List | |
1172 | 2018-04-10 | Petitioner | Ex. 1172 - email | |
1173 | 2018-04-10 | Petitioner | Ex. 1173 - email | |
2177 | 2018-04-10 | Potential Patent Owner | Exhibit from Donovan's Second Deposition | |
2178 | 2018-04-10 | Potential Patent Owner | Second Donovan Deposition Transcript | |
2179 | 2018-04-10 | Potential Patent Owner | Second Schleimer Deposition Transcript | |
2180 | 2018-04-10 | Potential Patent Owner | Staines Deposition Transcript | |
2181 | 2018-04-10 | Potential Patent Owner | EX1171 - Staines Deposition Exhibit 1171 | |
46 | 2018-04-24 | Potential Patent Owner | Other | Updated Mandatory Notices |
47 | 2018-04-24 | Potential Patent Owner | Other | Patent Owner's Opposition to Motion to Exclude |
48 | 2018-04-24 | Petitioner | Other | Opposition to Patent Owner's Motion To Exclude Evidence |
49 | 2018-04-24 | Petitioner | Other | Response to Patent Owner's Motion for Observations |
50 | 2018-04-24 | Petitioner | Petitioner's Exhibit List of April 24, 2018 | |
1037 | 2018-04-24 | Petitioner | Ex. 1037 | |
1043 | 2018-04-24 | Petitioner | Ex. 1043 | |
1170 | 2018-04-24 | Petitioner | Ex. 1170 | |
1174 | 2018-04-24 | Petitioner | Ex. 1174 | |
1175 | 2018-04-24 | Petitioner | Ex. 1175 | |
51 | 2018-04-26 | Board | Other | Conduct of the Proceeding |
52 | 2018-04-30 | Petitioner | Other | PETITIONER¿¿¿S REPLY TO PATENT OWNER¿¿¿S OPPOSITION TO PETITIONER¿¿¿S MOTION TO EXCLUDE |
53 | 2018-04-30 | Potential Patent Owner | Other | Patent Owner's Reply to Opposition to Motion to Exclude |
54 | 2018-05-11 | Potential Patent Owner | Other | Joint Motion to Limit Petition |
55 | 2018-05-11 | Potential Patent Owner | Other | Exhibit List |
2182 | 2018-05-11 | Potential Patent Owner | 2182 - Joint Stipulation to Limit Petition under 37 CFR 42.71 | |
56 | 2018-05-14 | Petitioner | Other | Petitioner's Objections to Patent Owner's Demonstrative Exhibit |
57 | 2018-05-14 | Potential Patent Owner | Other | Objections to Petitioner's Demonstratives |
58 | 2018-05-17 | Potential Patent Owner | Motion to Terminate | Joint Motion to Terminate Proceedings |
59 | 2018-05-17 | Potential Patent Owner | Other | Joint Request to File Settlement as BCI |
60 | 2018-05-21 | Board | Final Decision | Termination Decision Document |
61 | 2018-05-24 | Potential Patent Owner | Other | Motion to Expunge |
62 | 2018-05-29 | Board | Other | Granting Patent Owner's Motion to Expunge |
Grounds Asserted